Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Daniel Benz

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Current Drug Discovery Technologies|February 14, 2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modelingEdwin J Matthews, Naomi L Kruhlak, James L Weaver, et al.
Regulatory Toxicology and Pharmacology : RTP|December 15, 2005
An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methodsEdwin J Matthews, Naomi L Kruhlak, Michael C Cimino, et al.
Regulatory Toxicology and Pharmacology : RTP|January 3, 2006
An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpointsEdwin J Matthews, Naomi L Kruhlak, Michael C Cimino, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2006
A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicalsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Molecular Nutrition & Food Research|December 22, 2009
Testing computational toxicology models with phytochemicalsLuis G Valerio, Kirk B Arvidson, Emily Busta, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in RodentsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicitiesCarling J Ursem, Naomi L Kruhlak, Joseph F Contrera, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Environmental and Molecular Mutagenesis|May 4, 2011
Genetic toxicology in the 21st century: reflections and future directionsBrinda Mahadevan, Ronald D Snyder, Michael D Waters, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Carling J Ursem, Naomi L Kruhlak, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Current Drug Discovery Technologies|February 14, 2006
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modelingEdwin J Matthews, Naomi L Kruhlak, James L Weaver, et al.
Regulatory Toxicology and Pharmacology : RTP|December 15, 2005
An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: II. Identification of genotoxicants, reprotoxicants, and carcinogens using in silico methodsEdwin J Matthews, Naomi L Kruhlak, Michael C Cimino, et al.
Regulatory Toxicology and Pharmacology : RTP|January 3, 2006
An analysis of genetic toxicity, reproductive and developmental toxicity, and carcinogenicity data: I. Identification of carcinogens using surrogate endpointsEdwin J Matthews, Naomi L Kruhlak, Michael C Cimino, et al.
Regulatory Toxicology and Pharmacology : RTP|December 19, 2006
A comprehensive model for reproductive and developmental toxicity hazard identification: II. Construction of QSAR models to predict activities of untested chemicalsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Molecular Nutrition & Food Research|December 22, 2009
Testing computational toxicology models with phytochemicalsLuis G Valerio, Kirk B Arvidson, Emily Busta, et al.
Toxicology Mechanisms and Methods|December 22, 2009
Combined Use of MC4PC, MDL-QSAR, BioEpisteme, Leadscope PDM, and Derek for Windows Software to Achieve High-Performance, High-Confidence, Mode of Action-Based Predictions of Chemical Carcinogenesis in RodentsEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans. Part A: use of FDA post-market reports to create a database of hepatobiliary and urinary tract toxicitiesCarling J Ursem, Naomi L Kruhlak, Joseph F Contrera, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part C: use of QSAR and an expert system for the estimation of the mechanism of action of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Naomi L Kruhlak, R Daniel Benz, et al.
Environmental and Molecular Mutagenesis|May 4, 2011
Genetic toxicology in the 21st century: reflections and future directionsBrinda Mahadevan, Ronald D Snyder, Michael D Waters, et al.
Regulatory Toxicology and Pharmacology : RTP|May 8, 2009
Identification of structure-activity relationships for adverse effects of pharmaceuticals in humans: Part B. Use of (Q)SAR systems for early detection of drug-induced hepatobiliary and urinary tract toxicitiesEdwin J Matthews, Carling J Ursem, Naomi L Kruhlak, et al.
Pageof 3